CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 77939 | LVS EN ISO 10993-4:2017/A1:2025 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood - Amendment 1 (ISO 10993-4:2017/Amd 1:2025, Corrected version 2025-04) | Standarts spēkā |
| 62983 | EN ISO 14155:2020 | Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2020) | Standarts spēkā |
| 65727 | EN ISO 10993-4:2017 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017) | Standarts spēkā |
| 22089 | LVS EN ISO 10993-5:2009 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Standarts spēkā |
| 9493 | LVS EN ISO 10993-7:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Standarts spēkā |
| 80820 | LVS EN ISO 10993-5:2009/A11:2025 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 27051 | LVS EN ISO 10993-13:2010 | Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010) | Standarts spēkā |
| 64034 | EN ISO 10993-7:2008/A1:2022 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Amendment 1: Applicability of allowable limits for neonates and infants (ISO 10993-7:2008/Amd 1:2019) | Standarts spēkā |
| 60725 | LVS EN ISO 10993-18:2020 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020) | Standarts spēkā |
| 78989 | EN ISO 10993-12:2021/A1:2025 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials - Amendment 1 (ISO 10993 12:2021/Amd 1:2025) | Standarts spēkā |
Displaying 11-20 of 192 results.